Skip to content

Effect of preoperative dexmedetomidine nasal spray on postoperative resuscitation of patients undergoing thyroid surgery

Effect of preoperative dexmedetomidine nasal spray on postoperative resuscitation of patients undergoing thyroid surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500106404
Enrollment
Unknown
Registered
2025-07-23
Start date
2025-09-30
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thyroid surgery

Interventions

Group receiving intranasal dexmedetomidine (experimental group) :The experimental group used 0.2 ml of dexmedetomidine nasal spray (100 µg)
Group receiving intranasal saline (control group):The control group patients used 0.2 ml of saline nasal spray

Sponsors

Tianjin First Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Patients undergoing thyroidectomy under general anesthesia; 2. Age 18 ~ 60 years old; 3. ASA is graded as I ~ II; 4. Body mass index (BMI) 18~29 kg/m^2; 5. Patients with informed consent who are willing to participate in this trial.

Exclusion criteria

Exclusion criteria: 1. Contraindications to dexmedetomidine, including allergy or hypersensitivity to other anesthetics of dexmedetomidine; 2. Those who are not suitable for nasal spray administration, such as severe rhinitis and nasal deformity; 3. Sinus heart rate less than 45 beats per minute; 4. Second- or third-degree atrioventricular block; 5. Pregnant or lactating women; 6. Patients taking antihypertensive drugs, such as a-methyldopa, clonidine, or other a 2-adrenergic agonists; 7. Respiratory diseases: severe asthma, severe emphysema, severe bronchitis, severe chronic obstructive pulmonary disease; 8. Liver and kidney insufficiency; 9. Psychopaths; 10. Circulatory system diseases: previous myocardial infarction, unstable angina, severe heart arrhythmia, cardiac insufficiency; 11. Long-term use of sedatives and analgesics.

Design outcomes

Primary

MeasureTime frame
Coughing score;incidence of coughing;

Secondary

MeasureTime frame
Riker Agitation-Sedation Scale;Cold rating;Ramsay Sedation Scale Score;mechanical ventilation duration;Time spent in the post-anesthesia recovery room;Wrench cold rating;QoR-15 Score;The satisfaction of anesthesiologists' procedures;Incidence of agitation;

Countries

China

Contacts

Public ContactWeihua Liu

Tianjin First Central Hospital

442675987@qq.com+86 136 0215 6503

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026